Press Releases

04.22.2020

BioNTech and Pfizer announce regulatory approval from German authority Paul-Ehrlich-Institut to commence first clinical trial of COVID-19 vaccine candidates

04.09.2020

Pfizer and BioNTech Announce Further Details on Collaboration to Accelerate Global COVID-19 Vaccine Development

04.09.2020

Pfizer Advances Battle Against COVID-19 on Multiple Fronts

04.06.2020

Pfizer and The Pfizer Foundation Donate $40 Million in Charitable Grants, Expand Product Access and Mobilize Colleagues to Combat COVID-19 Pandemic

04.01.2020

Medical Professionals Across Merck & Co., Inc., Pfizer Inc., and Eli Lilly and Company Activate to Support Health Systems, First Responders and Patients Amid COVID-19 Pandemic

03.17.2020

Pfizer and BioNTech to Co-develop Potential COVID-19 Vaccine

03.17.2020

Pfizer and BioNTech to Co-Develop Potential COVID-19 Vaccine

03.13.2020

Pfizer Outlines Five-Point Plan to Battle COVID-19